• 1. Center for Biomedical Ethics, Fudan University, Shanghai 200433, P.R.China;
  • 2. School of Philosophy, Fudan University, Shanghai 200433, P.R.China;
  • 3. Human Phenome Institute, Fudan University, Shanghai 201203, P.R.China;
  • 4. School of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, P.R.China;
YIN Jie, Email: jieyin@fudan.edu.cn
Export PDF Favorites Scan Get Citation

In order to promote the responsible development of precision medicine in China, the current situation of precision medicine in three major fields (clinical, research and commercial) was briefly introduced, and key ethical issues or disputes in each field (including informed consent, return of incidental findings, and allocation of medical resources in the clinical field; informed consent, return of research results, and data use and sharing in the research field; genetic counseling, clinical utility of genetic testing, and use of data in the field of direct-to-consumer genetic testing) were discussed. It is necessary to actively meet these ethical challenges for the development of precision medicine in China.

Citation: PANG Cong, CHEN Hongyi, WANG Yifeng, YIN Jie. Ethical challenges of precision medicine in China. Chinese Journal of Evidence-Based Medicine, 2020, 20(12): 1367-1372. doi: 10.7507/1672-2531.202009019 Copy

  • Previous Article

    Further improve the reporting quality of clinical research in China
  • Next Article

    Construction of the evaluation method of personalized dynamic efficacy for traditional Chinese medicine from the perspective of the long time course